1,049
Views
0
CrossRef citations to date
0
Altmetric
Editorial

High degree atrioventricular block and COVID-19 infection: a two player match?

Pages 783-786 | Received 25 Aug 2022, Accepted 30 Sep 2022, Published online: 08 Oct 2022

References

  • Dagher L, Wanna B, Mikdadi G, et al. High-degree atrioventricular block in COVID-19 hospitalized patients. Europace. 2021 8; 23(3): 451–455.
  • Sardana M, Scheinman MM, Moss JD. Atrioventricular block after COVID-19: what is the mechanism, site of block, and treatment? Heart Rhythm. 2021 Mar;18(3): 489–490.
  • Aryanti RR, Hermanto DY, Yuniadi Y. Dynamic changes of atrioventricular conduction during Covid-19 infection: does inflammation matter? Int J Arrhythmia. 2022;23(1):20
  • Babapoor-Farrokhran S, Batnyam U, Wiener PC, et al. Atrioventricular and Sinus Node Dysfunction in Stable COVID-19 Patients. SN Compr Clin Med. 2020;2(11):1955–1958.
  • Nagamine T, Randhawa S, Nishimura Y, et al. Characteristics of bradyarrhythmia in patients with COVID-19: systematic scoping review. Pacing Clin Electrophysiol. 2022 Apr;45(4):556–566.
  • Abobaker ACOVID-19. infection as a possible cause of complete heart block: what do we know so far? Ann Noninvasive Electrocardiol. 2022 May;27(3):e12930.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506.
  • Wx S, RC L, Jq W, et al. Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19. Front Public Health. 2021;24(9):671788.
  • Carlson FR Jr, Bosukonda D, Keck PC, et al. Multiorgan Damage in Patients with COVID-19: is the TGF-β/BMP Pathway the Missing Link? JACC Basic Transl Sci. 2020Nov5;5(11):1145–1148.
  • Lazzerini PE, Acampa M, Cupelli M, et al. Unravelling atrioventricular block risk in inflammatory diseases: systemic inflammation acutely delays atrioventricular conduction via a cytokine-mediated inhibition of connexin43 expression. J Am Heart Assoc. 2021 Nov 2;10(21):e022095.
  • Cooreman A, Caufriez A, Tabernilla A, et al. Effects of drugs formerly proposed for COVID-19 treatment on connexin43 hemichannels. Int J Mol Sci. 2022 Apr 30;23(9):5018.
  • Saito A, Horie M, Micke P, et al. The Role of TGF-β Signaling in lung cancer associated with idiopathic pulmonary fibrosis. Int J Mol Sci. 2018 Nov 15;19(11):3611.
  • Wang EY, Chen H, Sun BQ, et al. Serum levels of the IgA isotype switch factor TGF-β1 are elevated in patients with COVID-19. FEBS Lett. 2021 Jul;595(13):1819–1824.
  • Ferreira-Gomes M, Kruglov A, Durek P, et al. SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself. Nat Commun. 2021 Mar 30;12(1):1961.
  • Salvarani N, Maguy A, De Simone SA, et al. TGF-β1 (transforming growth factor-β1) plays a pivotal role in cardiac myofibroblast arrhythmogenicity. Circ Arrhythm Electrophysiol. 2017 May;10(5):e004567.
  • Li J, Weinberg MS, Zerbini L, et al. The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway. Mol Biol Cell. 2013 Nov;24(22):3569–3576.
  • Nguyen HH, Grange DK, Johnson MC, et al. Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart. HeartRhythm Case Rep. 2018 Nov 20;5(2):109–111.
  • Bakker ML, Boink GJ, Boukens BJ, et al. T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells. Cardiovasc Res. 2012 Jun 1;94(3):439–449.
  • van Weerd JH, Mohan RA, van Duijvenboden K, et al. Trait-associated noncoding variant regions affect TBX3 regulation and cardiac conduction. Elife. 2020 Jul 16;9(ye):e56697.
  • Zimmerli D, Borrelli C, Jauregi-Miguel A, et al. TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. Elife. 2020 Aug;18(9):e58123.
  • Gillers BS, Chiplunkar A, Aly H, et al. Canonical wnt signaling regulates atrioventricular junction programming and electrophysiological properties. Circ Res. 2015 Jan 30;116(3):398–406.
  • Lorenzon A, Calore M, Poloni G, et al. Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy. Oncotarget. 2017 Apr 27;8(36):60640–60655.
  • Lu A, Kamkar M, Chu C, et al. Direct and Indirect Suppression of SCN5A gene expression mediates cardiac Na+ channel inhibition by Wnt signalling. Can J Cardiol. 2020 Apr;36(4):564–576.
  • Gao L, Yu X, Li H, et al. A case report of one vasovagal syncope patient with third-degree atrioventricular block caused by SCN5A gene mutation and literature review. BMC Pediatr. 2020 May 12;20(1):211.
  • Liu Y, Hong K. Study on the molecular genetic mechanism of third degree atrioventricular block and sodium channel SCN5A gene. Chin Cir J. 2015;(z1):31–32. Available from: https://doi.org/10.3969/j.issn.1000-3614.2015.z1.087

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.